Feb 08, 2021
Cystic Fibrosis is a rare inherited disorder that causes loss of lung function and damages the digestive system. It has a higher prevalence in the Caucasian population. For years there was no treatment available targeting the underlying cause, however, this changed in 2012 with the launch of Vertex Pharma’s Kalydec...
Read More...
Feb 05, 2021
Smoking is the leading preventable cause of death in the world. However, prior to 1900, tobacco smoking was an uncommon sight. It was not until the 20th century that smoking cigarettes became a routine or more precisely a popular trend among youths and adults. What helped in booming its adoption were effective adve...
Read More...
Feb 04, 2021
Plaque psoriasis drug outshines the competition in phase III trial Bristol Myers Squibb’s psoriasis drug, the TYK2 inhibitor outshone placebo and Amgen’s Otezla in a second phase 3 study, setting discussions with regulators. The study, known as POETYK PSO-2, trialled the drug, deucravacitinib, against placebo...
Read More...
Feb 03, 2021
Information and Communications Technology (ICT) over the past few years have changed the way of communication. Among all the communication mediums, social media, in particular, has got a lot of attention and offers a huge benefit over traditional media. It has empowered the common man to quickly and easily get acce...
Read More...
Feb 03, 2021
It is all about finding echoes of others within us! Holler folks! Welcome to Let's Hear It. Today, we bring you the second post of our series Let's Hear It. Earlier, we had a beautiful piece authored by our COO that highlighted the importance of Mental health. In this fast-paced life, we often forget or say negl...
Read More...
Feb 02, 2021
Horizon Therapeutics Bolsters its Rare Disease Portfolio in a $3B Viela Bio Buyout Horizon Therapeutics has announced to acquire Viela Bio for about $3.1 billion to augment its portfolio and pipeline of treatments for rare diseases. The shares of Viela Bio skyrocketed more than 52% in premarket trading after the...
Read More...
Feb 01, 2021
Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. However, what if cough decides to befriend the person for a time period more than usual, say, around eight weeks or more? It can be worrisome, and...
Read More...
Jan 29, 2021
Bananas! Mostly everyone loves bananas. Who wouldn’t? They taste good and they are a rich source of potassium. Besides lovely bananas, oranges, cantaloupe, honeydew, apricots, grapefruit, red meat are some other rich sources of potassium that people include in their diets. On average, a healthy human body needs 4,7...
Read More...
Jan 28, 2021
Nirogy Therapeutics rises with USD 16.5 Million to target metabolite transporters Nirogy Therapeutics Inc., a privately-held biotechnology company developing novel small molecules for targeting cellular transporters, announced the closing of a USD 16.5 million Series A financing. Nirogy plans to use the...
Read More...
Jan 27, 2021
As per the National Association of Anorexia Nervosa and Associated Disorders, (ANAD), worldwide, at least 9% of the population is affected by eating disorders. Eating disorders is a psychological condition that disturbs eating habits. Eating disorders affect thoughts and emotions, and the people with the disease be...
Read More...